Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
Conditions
- Multiple Myeloma or Amyloidosis
Interventions
- DEVICE: Subcutaneous Daratumumab Administration Using FreedomEDGE®
Sponsor
Hospices Civils de Lyon
Collaborators